Real-world clinical practice, effectiveness and safety of esketamine nasal spray in major depressive disorder patients: a French prospective cohort (ELLIPSE study).

Llorca PM, Sauvaget A, Olié E, Mékaoui L, Samalin L, Rothärmel M, Boitez AL, Dupin J, Wicart C, Gaudre-Wattinne E, Lacour H, Grenier B, Astruc B, Falissard B, de Maricourt P

Open source

DOI
10.1177/20451253261463652
Published
2026
Container
Therapeutic advances in psychopharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/20451253261463652,
  title = {Real-world clinical practice, effectiveness and safety of esketamine nasal spray in major depressive disorder patients: a French prospective cohort (ELLIPSE study).},
  author = {Llorca PM and Sauvaget A and Olié E and Mékaoui L and Samalin L and Rothärmel M and Boitez AL and Dupin J and Wicart C and Gaudre-Wattinne E and Lacour H and Grenier B and Astruc B and Falissard B and de Maricourt P},
  year = {2026},
  journal = {Therapeutic advances in psychopharmacology},
  doi = {10.1177/20451253261463652},
  url = {https://doi.org/10.1177/20451253261463652}
}

RIS

TY  - JOUR
TI  - Real-world clinical practice, effectiveness and safety of esketamine nasal spray in major depressive disorder patients: a French prospective cohort (ELLIPSE study).
AU  - Llorca PM
AU  - Sauvaget A
AU  - Olié E
AU  - Mékaoui L
AU  - Samalin L
AU  - Rothärmel M
AU  - Boitez AL
AU  - Dupin J
AU  - Wicart C
AU  - Gaudre-Wattinne E
AU  - Lacour H
AU  - Grenier B
AU  - Astruc B
AU  - Falissard B
AU  - de Maricourt P
PY  - 2026
JO  - Therapeutic advances in psychopharmacology
DO  - 10.1177/20451253261463652
UR  - https://doi.org/10.1177/20451253261463652
ER  - 

APA

PM, L., A, S., E, O., L, M., L, S., M, R., AL, B., J, D., C, W., E, G., H, L., B, G., B, A., B, F., & P, D. M. (2026). Real-world clinical practice, effectiveness and safety of esketamine nasal spray in major depressive disorder patients: a French prospective cohort (ELLIPSE study).. Therapeutic advances in psychopharmacology. https://doi.org/10.1177/20451253261463652

Source records